Target Name: OGFR
NCBI ID: G11054
Review Report on OGFR Target / Biomarker Content of Review Report on OGFR Target / Biomarker
OGFR
Other Name(s): OGFr | OGFR_HUMAN | Opioid growth factor receptor | zeta-type opioid receptor | Protein 7-60 | protein 7-60 | 7-60 protein | Zeta-type opioid receptor | opioid growth factor receptor

OGFR: A Potential Drug Target and Biomarker

OGFR (Ogfr) is a protein that is expressed in human tissues and has been identified as a potential drug target and biomarker. It is a member of the TGF-β family, which is involved in cell growth, differentiation, and survival. OGFR is a 21-kDa transmembrane protein that is expressed in various tissues, including muscle, liver, and brain. It is involved in the regulation of cell proliferation, differentiation, and survival, and is thought to play a key role in the development and progression of many diseases.

One of the key functions of OGFR is its role in cell proliferation and differentiation. OGFR is involved in the regulation of cell growth and has been shown to play a key role in the regulation of cell proliferation in various tissues. For example, studies have shown that OGFR is involved in the regulation of cell proliferation in muscle cells, and that it plays a role in the development of muscle cancer.

Another function of OGFR is its role in cell survival and differentiation. OGFR is involved in the regulation of cell survival and has been shown to play a key role in the regulation of cell survival in various tissues. For example, studies have shown that OGFR is involved in the regulation of cell survival in cancer cells, and that it plays a role in the development of cancer.

OGFR is also involved in the regulation of cellular signaling pathways. It is a component of several signaling pathways, including the TGF-β signaling pathway and the Wnt signaling pathway. The TGF-β signaling pathway is involved in the regulation of cell growth, differentiation, and survival, and is thought to play a key role in the development and progression of many diseases. The Wnt signaling pathway is involved in the regulation of cell growth and development, and is also thought to play a key role in the development and progression of many diseases.

OGFR is also involved in the regulation of tissue repair and regeneration. It is a component of several processes that are involved in tissue repair and regeneration, including the regulation of cell proliferation and the formation of new tissues.

In conclusion, OGFR is a protein that is involved in a wide range of physiological processes in the body. It is a potential drug target and biomarker, and its role in the regulation of cell proliferation, differentiation, survival, and signaling pathways makes it an attractive target for further research. Further studies are needed to fully understand the role of OGFR in the development and progression of many diseases, and to develop new treatments based on its properties as a potential drug target and biomarker.

Protein Name: Opioid Growth Factor Receptor

Functions: Receptor for opioid growth factor (OGF), also known as Met-enkephalin. Seems to be involved in growth regulation

The "OGFR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OGFR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OGFR-AS1 | OGFRL1 | OGFRP1 | OGG1 | OGN | OGT | OIP5 | OIP5-AS1 | OIT3 | OLA1 | OLA1P1 | OLAH | OLFM1 | OLFM2 | OLFM3 | OLFM4 | OLFML1 | OLFML2A | OLFML2B | OLFML3 | OLIG1 | OLIG2 | OLIG3 | Oligosaccharyltransferase complex | OLMALINC | OLR1 | OMA1 | OMD | OMG | OMP | Oncostatin-M Receptor | ONECUT1 | ONECUT2 | ONECUT3 | OOEP | OOSP1 | OOSP2 | OPA1 | OPA1-AS1 | OPA3 | OPALIN | OPCML | OPHN1 | Opioid receptor | OPLAH | OPN1LW | OPN1MW | OPN1MW3 | OPN1SW | OPN3 | OPN4 | OPN5 | OPRD1 | OPRK1 | OPRL1 | OPRM1 | OPRPN | OPTC | OPTN | OR10A2 | OR10A3 | OR10A4 | OR10A5 | OR10A6 | OR10A7 | OR10AA1P | OR10AB1P | OR10AC1 | OR10AD1 | OR10AF1P | OR10AG1 | OR10AK1P | OR10C1 | OR10D1P | OR10D3 | OR10D4P | OR10G2 | OR10G3 | OR10G4 | OR10G7 | OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1